Patent · US Active

Cycloalkyl substituted pyrimidinediamine compounds and their uses

US9725419B2 · kind B2 · utility

7Cited by

13References

3Claims

0Family size

Assignee

Rigel Pharmaceuticals, Inc. · US

Inventors

Hui Li · Santa Clara, US
Ankush Argade · Foster City, US
Rajinder Singh · Belmont, US
Sambaiah Thota · Fremont, US
David Carroll · San Francisco, US
Kin Tso · San Francisco, US
Vanessa Taylor · San Francisco, US
John McLaughlin · Media, US
Vadim Markovtsov · San Mateo, US

Key dates

Filing date	Feb 1, 2013
Grant date	Aug 8, 2017
Priority date	—
Expiry date	Apr 5, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.